Paclitaxel Powder 99.0%

Short Description:

Paclitaxel is a monomer diterpenoid compound extracted from Natural Plant Paclitaxel bark, is a kind of complex secondary metabolites, is currently understood only a drug can promote microtubule polymerization and stability of microtubules have been aggregated. Isotope tracing showed that paclitaxel was bound only to polymerized microtubules, not to the polymerized tubulin two. Cell contact paclitaxel after the accumulation of a large number of microtubules in cells, which interfere with microtubule accumulation of various cellular functions, especially the cell division stop in mitosis, blocking the normal cell division


  • FOB Price: US 5 - 2000 / KG
  • Min.Order Quantity: 1 KG
  • Supply Ability: 10000 KG/per Month
  • Port: Shanghai /Beijing
  • Payment Terms: L/C,D/A,D/P,T/T,O/A
  • Shipping Terms: By sea/By Air/By Courier
  • E-mail:: info@trbextract.com
  • Product Detail

    Product Tags

    Product Name:Paclitaxel 99.0%

    Form:White crystalline powder
    Specification: 99%

    Test Method : HPLC

    CAS Number: 33069-62-4

    Molecular Formula:C47H51NO14

    Boiling Point:957.115 °C at 760 mmHg
    Molecular Weight:  853.91
    GMO Status:GMO Free

    Packing: in 25kgs fiber drums

    Storage:Keep container unopened in cool, dry place,Keep away from strong light

    Shelf Life:24 months from date of production

    Product Name: Paclitaxel Powder 99.0% (C47H51NO14)
    CAS No.: 33069-62-4
    Molecular Weight: 853.91
    Purity: ≥99.0% (HPLC Verified)

    Product Overview

    Paclitaxel Powder 99.0% is a highly purified, plant-derived anticancer agent widely used in chemotherapy for solid tumors, including breast, ovarian, and non-small-cell lung cancers. Extracted via advanced fermentation or plant cell culture technology, this product ensures eco-friendly production and consistent quality . Its mechanism involves stabilizing microtubules during the G2/M phase, inhibiting cell division, and inducing apoptosis .

    Key Features

    1. High Purity & Quality Control:
      • Purity ≥99.0% (HPLC), with stringent impurity limits (e.g., total impurities ≤0.5%, individual impurities ≤0.1%) .
      • Complies with USP34 standards, validated for identity, solubility, and stability .
    2. Physicochemical Properties:
      • Appearance: White crystalline powder .
      • Solubility: Insoluble in water; soluble in methanol, ethanol, and DMSO (50 mg/mL) .
      • Storage: Stable at 2–8°C in airtight, light-protected containers .
    3. Safety & Compliance:
      • Low endotoxin levels (≤0.4 USP EU/mg) and heavy metal content (≤20 ppm) .
      • Supported by clinical trials demonstrating efficacy and safety in cancer treatment .

    Applications

    • Oncology: First-line therapy for breast, ovarian, and lung cancers, often combined with cisplatin or docetaxel .
    • Research: Used in nanoparticle formulations (e.g., liposomes, micelles) to enhance bioavailability and reduce toxicity .
    • Pharmaceutical Development: Ideal for injectable formulations and oral delivery systems .

    Technical Specifications

    Parameter Value
    Purity (HPLC) ≥99.0%
    Melting Point 213°C (dec.)
    Optical Rotation -49° to -55° (c=1, MeOH)
    Water Content ≤4.0%
    Microbial Limits ≤100 CFU/g
    CAS No. 33069-62-4

    Packaging & Ordering

    • Available Sizes: 10 mg, 20 mg, 50 mg (customizable bulk orders).
    • Packaging: Sealed amber vials with desiccant to ensure stability.
    • Shelf Life: 3 years under recommended storage conditions .

    Why Choose Our Product?

    • Sustainable Sourcing: Produced via plant cell culture technology, reducing reliance on endangered yew trees .
    • Global Compliance: Meets USP, ICH, and ISO guidelines for pharmaceutical ingredients .
    • Technical Support: Full analytical reports (COA, MSDS) and customized formulation guidance provided.

    Keywords

    Paclitaxel Powder 99.0%, USP34 Standard, Anticancer Drug, Microtubule Stabilizer, High Purity Taxol, Breast Cancer Treatment, Nanoparticle Formulation, GMP-Certified.


  • Previous:
  • Next: